Dhou S, Hurwitz M, Mishra P, Cai W, Rottmann J, Li R, Williams C, Wagar M, Berbeco R, Ionascu D, Lewis J H
Department of Radiation Oncology, Brigham and Women's Hospital, Dana-Farber Cancer Institute, and Harvard Medical School, Boston, MA, USA.
Phys Med Biol. 2015 May 7;60(9):3807-24. doi: 10.1088/0031-9155/60/9/3807. Epub 2015 Apr 23.
3D fluoroscopic images represent volumetric patient anatomy during treatment with high spatial and temporal resolution. 3D fluoroscopic images estimated using motion models built using 4DCT images, taken days or weeks prior to treatment, do not reliably represent patient anatomy during treatment. In this study we developed and performed initial evaluation of techniques to develop patient-specific motion models from 4D cone-beam CT (4DCBCT) images, taken immediately before treatment, and used these models to estimate 3D fluoroscopic images based on 2D kV projections captured during treatment. We evaluate the accuracy of 3D fluoroscopic images by comparison to ground truth digital and physical phantom images. The performance of 4DCBCT-based and 4DCT-based motion models are compared in simulated clinical situations representing tumor baseline shift or initial patient positioning errors. The results of this study demonstrate the ability for 4DCBCT imaging to generate motion models that can account for changes that cannot be accounted for with 4DCT-based motion models. When simulating tumor baseline shift and patient positioning errors of up to 5 mm, the average tumor localization error and the 95th percentile error in six datasets were 1.20 and 2.2 mm, respectively, for 4DCBCT-based motion models. 4DCT-based motion models applied to the same six datasets resulted in average tumor localization error and the 95th percentile error of 4.18 and 5.4 mm, respectively. Analysis of voxel-wise intensity differences was also conducted for all experiments. In summary, this study demonstrates the feasibility of 4DCBCT-based 3D fluoroscopic image generation in digital and physical phantoms and shows the potential advantage of 4DCBCT-based 3D fluoroscopic image estimation when there are changes in anatomy between the time of 4DCT imaging and the time of treatment delivery.
三维荧光透视图像在治疗过程中以高空间和时间分辨率呈现患者的体积解剖结构。使用治疗前数天或数周获取的4DCT图像构建的运动模型估算出的三维荧光透视图像,并不能可靠地呈现治疗过程中的患者解剖结构。在本研究中,我们开发并初步评估了从治疗前即刻获取的4D锥形束CT(4DCBCT)图像中生成患者特异性运动模型的技术,并使用这些模型根据治疗期间捕获的二维千伏投影估算三维荧光透视图像。我们通过与地面真值数字和物理体模图像进行比较来评估三维荧光透视图像的准确性。在模拟肿瘤基线移位或初始患者定位误差的临床情况下,比较了基于4DCBCT和基于4DCT的运动模型的性能。本研究结果表明,4DCBCT成像能够生成运动模型,该模型可以解释基于4DCT的运动模型无法解释的变化。在模拟肿瘤基线移位和高达5毫米的患者定位误差时,基于4DCBCT的运动模型在六个数据集中的平均肿瘤定位误差和第95百分位数误差分别为1.20毫米和2.2毫米。应用于相同六个数据集的基于4DCT的运动模型的平均肿瘤定位误差和第95百分位数误差分别为4.18毫米和5.4毫米。还对所有实验进行了体素级强度差异分析。总之,本研究证明了在数字和物理体模中基于4DCBCT生成三维荧光透视图像的可行性,并显示了在4DCT成像时间与治疗交付时间之间解剖结构发生变化时,基于4DCBCT的三维荧光透视图像估计的潜在优势。